Villalón-López JS, Alonso-Briones MV, Souto-del Bosque R, López-Gaytán T

Language: Spanish
References: 10
Page: 553-558
PDF size: 215.05 Kb.

ABSTRACT

Background: the pericardiocenthesis is indicated as treatment of cardiac tamponade. The prevention of recurrences can be achieve by pericardial instillation of sclerosing agents, radionuclide agents as well as external beam radiotherapy that had given good results in radiosensitivity tumors. Pericardial window, pleuropericardiotomy, pericardiec-tomie and percutaneous pericardiotomie, are used when the pericardiocenthesis cannot be carried out.
Clinical case: a female patient, 34 years with cardiac tamponade was attended in the emergency room due to hemopericardium and pericardial metastases of unknown primary tumor. She was managed with pericardial window and systemic chemotherapy. After two year, she is alive without evidence of pericardial effusion recurrence and without evidence of tumor activity.
Conclusions: pericardiocentesis is an indication in cardiac tamponade. The multimodal treatment provides better results in patients with metastases to the pericardium and cardiac tamponade. It includes local and systemic chemotherapy and radiation therapy.

REFERENCES

1. Reynen K, Köckeritz U, Strasser RH. Metastases to the heart. Ann Oncol 2004;15(3):375-381. Disponible en http:// annonc.oxfordjournals.org/content/15/3/375.long

2. Maisch B, RistiC AD, Pankuweit S, Neubauer A, Moll R. Neoplasic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 2002; 23(20):1625-1631.

3. Kobayashi M, Okabayashi T, Okamoto K, Namikawa T, Araki K. Clinicopathological study of cardiac tamponade due to pericardial metastases originating from gastric cancer. World J Gastroenterol 2005;11(44):6899-6904.

4. Chandraratna PA, Aronow WS. Detection of pericardial metastases by cross-sectional echocardiography. Circulation 1981;63(1):197-199.

5. Cisneros A, García J, Castellanos G. Taponamiento cardiaco secundario a metástasis de adenocarcinoma gástrico en pericardio. Informe de un caso de autopsia. Med Int Mex 2010;26(6):629-633.

6. Laissy JP, Fernández P, Mousseaux E. Tumeurs cardiaques. J Radiol 2004;85(4 Pt 1):363-369.

7. Maisch B, Seferovic PM, RistiC AD, Erbel R, Rienmüller R, Adler Y, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary. The task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 2004;25 (7):587-610. Disponible en http://eurheartj.oxfordjournals. org/content/25/7/587.long

8. Escobar A, Beltrán R, Buitrago R. Taponamiento cardiaco en pacientes con neoplasia maligna conocida. Rev CES Med 2002;16(1):35-38.

9. O’Brien PK, Kucharczuk JC, Marshall MB, Friedberg JS, Chen Z, Kaiser LR, et al. Comparative study of subxiphoid versus video-thoracoscopic pericardial “window”. Ann Thorac Surg 2005;80(6):2013-2019.

10. Kelly-García J, Briceño-Anjona N, Fernández-Corzo MA, García-Bazán EM, Zamora-Lemus D, Ibarra-Pérez C. Tratamiento conservador del derrame pericárdico maligno con mitomicina C y lidocaína. GAMO 2005;4(4):84-87.